Evidence map›Paper›PMID 29867188›Full record

ArticleMolecular psychiatry2018

The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau.

Lin-Lin Shen, Noralyn B Mañucat-Tan, Shi-Hao Gao, Wei-Wei Li, Fan Zeng, Chi Zhu, Jun Wang, Xian-Le Bu, Yu-Hui Liu, Chang-Yue Gao and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Lin-Lin Shen *Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Noralyn B Mañucat-Tan *School of Pharmacy and Medical Sciences and Sansom Institute, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia.
Shi-Hao GaoDepartment of Neurobiology, College of Basic Medical Science, Chongqing Key Laboratory of Neurobiology, Third Military Medical University, 400038, Chongqing, China.
Wei-Wei LiDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Fan ZengDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Chi ZhuDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Jun WangDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Xian-Le BuDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Yu-Hui LiuDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Chang-Yue GaoDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Zhi-Qiang XuDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Larisa BobrovskayaSchool of Pharmacy and Medical Sciences and Sansom Institute, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia.
Peng LeiWest China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, China.ORCID http://orcid.org/0000-0001-5652-1962
Jin-Tai YuDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.ORCID http://orcid.org/0000-0002-7686-0547
Weihong SongTownsend Family Laboratories, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada.
Hua-Dong ZhouDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China.
Xiu-Qing YaoDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China. dryaoxq@163.com.
Xin-Fu ZhouSchool of Pharmacy and Medical Sciences and Sansom Institute, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia. xin-fu.zhou@unisa.edu.au.
Yan-Jiang WangDepartment of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China. yanjiang_wang@tmmu.edu.cn.ORCID http://orcid.org/0000-0002-6227-6112
Army Medical University · CNUniversity of South Australia · AUQingdao University · CNUniversity of British Columbia · CAWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tau pathology is characterized as a form of frontotemporal lobar degeneration (FTLD) known as FTLD-tau. The underlying pathogenic mechanisms are not known and no therapeutic interventions are currently available. Here, we report that the neurotrophin receptor p75NTR plays a critical role in the pathogenesis of FTLD-tau. The expression of p75NTR and the precursor of nerve growth factor (proNGF) were increased in the brains of FTLD-tau patients and mice (P301L transgenic). ProNGF-induced tau phosphorylation via p75NTR in vitro, which was associated with the AKT/glycogen synthase kinase (GSK)3β pathway. Genetic reduction of p75NTR in P301L mice rescued the memory deficits, alleviated tau hyperphosphorylation and restored the activity of the AKT/GSK3β pathway. Treatment of the P301L mice with the soluble p75NTR extracellular domain (p75ECD-Fc), which can antagonize neurotoxic ligands of p75NTR, effectively improved memory behavior and suppressed tau pathology. This suggests that p75NTR plays a crucial role in tau paGSKthology and represents a potential druggable target for FTLD-tau and related tauopathies.

Indexed as

AnimalsBrainCells, CulturedFemaleFrontotemporal Lobar DegenerationGlycogen Synthase Kinase 3 betaMaleMemory DisordersMice, TransgenicNerve Growth FactorNeuronsPhosphorylationPrimary Cell CultureProtein PrecursorsProto-Oncogene Proteins c-aktReceptors, Nerve Growth FactorGlycogen Synthase Kinase 3 betaNerve Growth FactorProtein PrecursorsProto-Oncogene Proteins c-aktReceptors, Nerve Growth Factortau Proteins

Identifiers

PMID29867188
OpenAlexW2806370916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.